A case study on decentralized manufacturing of 3D printed medicines

Pharmaceutical 3D printing (3DP) is one of the emerging enabling technologies of personalised medicines as it affords the ability to fabricate highly versatile dosage forms. In the past 2 years, national medicines regulatory authorities have held consultations with external stakeholders to adapt reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Seoane-Viaño, Iria, Xu, Xiaoyan, Ong, Jun Jie, Teyeb, Ahmed, Gaisford, Simon, Campos-Álvarez, André, Stulz, Anja, Marcuta, Carmen, Kraschew, Lilia, Mohr, Wolfgang, Basit, Abdul W., Goyanes, Alvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314212/
https://www.ncbi.nlm.nih.gov/pubmed/37396623
http://dx.doi.org/10.1016/j.ijpx.2023.100184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314212/
https://www.ncbi.nlm.nih.gov/pubmed/37396623
http://dx.doi.org/10.1016/j.ijpx.2023.100184

Ejemplares similares